Alpha Tau Medical DRTS
NASDAQ DRTS
$15.03 +0.41 (+2.80%)
As of: Sep 4, 2026 · 3:59 PM EDT

Alpha Tau Medical (DRTS) Total Debt Growth (1y) (2024 - 2026)

Analysis

Alpha Tau Medical (DRTS) Total Debt Growth (1y) (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (1y) (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 0.10%
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 12.42%
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 3.78%
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 0.00%
10 Alpha Tau Medical 1.21 Bn 1.11 Bn - 12.78%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 12.78%
Mar 31, 2026 17.01%
Dec 31, 2025 14.22%
Sep 30, 2025 12.24%
Jun 30, 2025 11.50%
Mar 31, 2025 -0.98%
Dec 31, 2024 -0.87%